Pharvaris director sells 52,500 shares at $37.89
A Pharvaris N.V. director exercised options for 52,500 shares and sold all resulting common stock in a same-day cashless transaction.
Rhea-AI Filing Summary
Pharvaris N.V. (PHVS) director Elisabeth Bjork exercised stock options and sold the resulting shares on September 17, 2026. She exercised options for 35,000 shares at 14.3900 per share and 17,500 shares at 18.1400 per share, then sold 52,500 common shares in a cashless exercise transaction at a weighted average price of 37.8935 per share, with individual sale prices ranging from 37.62 to 38.05.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 52,500 shares ($1.17M approx. pre-tax spread)
Exercise and Sale
5 txns
Insider
Bjork Elisabeth
Role
Director
Sold
52,500 shs ($1.99M)
Approx. gross sale proceeds
$1.99M
Approx. exercise cost
$821K
Approx. pre-tax spread
$1.17M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F2 | 35,000 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F3 | 17,500 | $0.00 | $0.00 |
| Exercise | Common Stock | 35,000 | $14.39 | $504K |
| Exercise | Common Stock | 17,500 | $18.14 | $317K |
| Sale | Common Stock F1 | 52,500 | $37.8935 | $1.99M |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 contracts (Direct);
Common Stock — 15,167 shares (Direct)
Footnotes (3)
- F1. The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $37.62 to $38.05. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F2. 25% of the option vested on January 1, 2023 with the remaining shares vesting in 1/48 monthly installments thereafter.
- F3. 25% of the option vested on April 1, 2023 with the remaining shares vesting in 1/48 monthly installments thereafter.
Key Figures
Shares sold: 52,500 shares
Weighted average sale price: 37.8935 per share
Sale price range: 37.62–38.05 per share
+4 more
7 metrics
Shares sold
52,500 shares
Common stock sold on September 17, 2026
Weighted average sale price
37.8935 per share
Common stock sales on September 17, 2026
Sale price range
37.62–38.05 per share
Price range for multiple sale transactions on September 17, 2026
Option exercise price 1
14.3900 per share
Stock option on 35,000 underlying shares exercised September 17, 2026
Option exercise price 2
18.1400 per share
Stock option on 17,500 underlying shares exercised September 17, 2026
Underlying shares exercised
52,500 shares
Total common shares underlying options exercised on September 17, 2026
Option expiration dates
January 1, 2032 and April 1, 2032
Expiration dates of exercised stock options
Key Terms
cashless exercise transaction, weighted average sale price, stock options, vesting
4 terms
cashless exercise transaction financial
"The shares were sold in connection with the exercise of stock options in a cashless exercise transaction."
weighted average sale price financial
"The reported price represents a weighted average sale price for shares sold in multiple transactions."
stock options financial
"The shares were sold in connection with the exercise of stock options in a cashless exercise transaction."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
vesting financial
"25% of the option vested on January 1, 2023 with the remaining shares vesting in 1/48 monthly installments thereafter."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transactions did Pharvaris (PHVS) director Elisabeth Bjork report on this Form 4?
She exercised stock options for 52,500 shares of common stock and sold 52,500 shares on September 17, 2026 in a cashless exercise transaction.
What stock options did the Pharvaris (PHVS) director exercise in this filing?
She exercised options covering 35,000 shares at 14.3900 per share and 17,500 shares at 18.1400 per share, for a total of 52,500 underlying common shares.
Was the Pharvaris (PHVS) director’s sale part of a cashless exercise?
Yes. A footnote states the shares were sold in connection with the exercise of stock options in a cashless exercise transaction, with multiple sale prices used to cover the exercise.
Were the Pharvaris (PHVS) transactions under a Rule 10b5-1 trading plan?
No Rule 10b5-1 plan is reported. The filing’s Rule 10b5-1 checkbox is not marked as an affirmative trading plan for these transactions.
What are the vesting terms of the Pharvaris (PHVS) options exercised by the director?
For one option, 25% vested on January 1, 2023 with the remainder vesting in 1/48 monthly installments. For the other, 25% vested on April 1, 2023 with the balance also vesting in 1/48 monthly installments.
AI-generated analysis. How Rhea-AI works. Not financial advice.
